Skip to main content
Premium Trial:

Request an Annual Quote

Peter Brocklesby Joins Applied DNA Sciences as President; Robin Jackman Goes from Sequenom to Vical; Hans Baum new VP at Bruker Daltonics; Lee Hood, Gene Myers, Martin Vingron, John Yates Win Awards

This column has been updated from an earlier version to correct information about John Yates' achievements.

 

Peter Brocklesby has become president of Applied DNA Sciences, the Los Angeles-based security company said today. He used to be vice president of marketing for E-Systems, a defense contractor. He also worked as an independent businessman, developing electronics systems for aircrafts in a joint venture with defense contractor Pleesey.


 

Robin Jackman has become vice president for business development of San Diego-based Vical, the company said yesterday. He joins the company from Sequenom, where he was vice president of corporate development. Jackman holds a PhD in immunology from Harvard University, a master's degree in medicine from Harvard Medical School, and a BS in biological science from Stanford University.


 

Hans Baum has been appointed vice president of European operations of Bruker Daltonics, the company said yesterday. He has held various positions at Bruker Daltonik in Germany since 1987.


 

Martin Vingron and Gene Myers have received this year's Max Planck Research Prize, the Max Planck Society said last month. The award ceremony will take place in Stuttgart, Germany, on June 24. Vingron is a professor of computational molecular biology and a director at the Max Planck Institute for Molecular Genetics in Berlin. Myers is a professor of computer science and molecular biology at the University of California in Berkeley. With the prize, which promotes collaborations between scientists in Germany and abroad, the researchers will each receive €750,000.


 

Leroy Hood will receive the 6th annual Biotechnology Heritage Award, The Chemical Heritage Foundation and the Biotechnology Industry Organization said in April. The presentation will be made next Monday at BIO 2004 in San Francisco. CHF and BIO are honoring Hood for his role in developing automated sequencing technology. Hood is the president and co-founder of the Institute for Systems Biology in Seattle. He holds a PhD in biochemistry from Caltech and an MD from Johns Hopkins University.


 

John Yates won the Biemann medal last week at the American Society for Mass Spectrometry's annual meeting in Nashville, Tenn. The medal, presented in honor of Klaus Biemann, recognizes a "significant achievement in basic or applied mass spectrometry made by an individual early in his or her career." Yates won for his development of protein analysis techniques, including the Sequest search algorithm he developed at the University of Washington.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.